Frankfurt - Delayed Quote EUR

Rhythm Pharmaceuticals, Inc. (1RV.F)

53.50
+2.50
+(4.90%)
At close: May 16 at 3:48:54 PM GMT+2

Research Analysis

Revenue vs. Earnings

Revenue 32.7M
Earnings -50.82M

Q2'24

Q3'24

Q4'24

Q1'25

-40M
-20M
0
20M
40M
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 11111212
Avg. Estimate 43.72M46.92M175.49M304.03M
Low Estimate 41.5M45M170M231.4M
High Estimate 47.3M48.71M182.33M400M
Year Ago Sales 29.08M33.25M130.13M175.49M
Sales Growth (year/est) 50.34%41.12%34.86%73.25%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
1RV.F --------
S&P 500 13.21%2.76%7.83%13.78%

Upgrades & Downgrades

Maintains Needham: Buy to Buy 5/7/2025
Maintains B of A Securities: Buy to Buy 4/10/2025
Reiterates HC Wainwright & Co.: Buy to Buy 4/8/2025
Maintains Canaccord Genuity: Buy to Buy 4/8/2025
Reiterates Needham: Buy to Buy 4/8/2025
Maintains Wells Fargo: Overweight to Overweight 4/7/2025

Related Tickers